Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Rob Jones

- PMLiVE

ICON’s CEO named chair of ACRO

Trade body for clinical research organisation elects Ciaran Murray

- PMLiVE

New year, new attitudes in digital

The real digital innovations in 2014 need to come in our attitudes, not our technologies

Shire Basingstoke

Shire faces $650m loss on Dermagraft sale

Sells struggling foot ulcer treatment to Organogenesis

- PMLiVE

Ipragliflozin beats diabetes rivals to Japanese approval

Astellas drug is first SGLT2 inhibitor backed by country’s regulator

- PMLiVE

Xarelto should not be approved in ACS says FDA panel

Advisory committee votes against new indication for Bayer and J&J’s anticoagulant

- PMLiVE

Journal questions publishing of industry-backed research

Former BMJ editor compares pharma research to tobacco-funded studies

- PMLiVE

Cancer Research UK to recruit its own ‘Wikipedian’

New in-house role will be funded by the Wellcome Trust and supported by Wikimedia UK

- PMLiVE

Horizon appoints board chair

Dr Ian Gilham assumes position full-time

- PMLiVE

This month in 2000: The formation of GSK

The twenty-first century’s first ‘mega merger’

- PMLiVE

AZ’s Soriot upbeat on firm’s prospects

Says pharma company can return to growth by 2017

Sanofi reception

Sanofi forms antibiotic research partnership

Will team up with Germany’s Fraunhofer-Gesellschaft to develop naturally-derived substances

- PMLiVE

FDA panel backs Merck’s vorapaxar

On course for US approval to reduce vascular events in certain patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links